Literature DB >> 16281436

Factors associated with reduced FEV1 in adult patients with cystic fibrosis in a relatively affluent area.

N A Jarad1, S Higgs, T Jeffcote, K Giles.   

Abstract

Data collected on adult cystic fibrosis (CF) patients and entered onto the CF database in the south and west regions of England were analysed for the year 2001. FEV1 was taken as a marker of lung disease severity. Data on 371 patients (158 female) mean age 24.7 years (range 16.0-48.9) were assessed. FEV1 was reduced in CF patients infected with Pseudomonas aeruginosa (Pa) (mean 62.6% predicted) compared with those without (mean FEV1 77.8%, P < 0.00001). The reduction was noted irrespective of age group. FEV1 progressively reduced with the increasing need for high-intensity treatment (P < 0.00001) and with the diagnosis of diabetes mellitus (P = 0.03). FEV1 correlated with body mass index (BMI) (r = + 0.42, P < 0.0001). Genetic profile and poverty and deprivation score did not affect the value of FEV1. Chronic infection with Pa mainly in young adults, treatment intensity, diabetes mellitus and reduced body mass index are associated with reduced FEV1 in adult patients with cystic fibrosis in the south and west regions of England. In this relatively affluent area, scores of poverty and deprivation were not associated with the decline in lung function tests.

Entities:  

Mesh:

Year:  2005        PMID: 16281436     DOI: 10.1191/1479972305cd065oa

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  5 in total

1.  Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis.

Authors:  Tasma Harindhanavudhi; Qi Wang; Jordan Dunitz; Antoinette Moran; Amir Moheet
Journal:  J Cyst Fibros       Date:  2019-11-11       Impact factor: 5.482

2.  Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches.

Authors:  Sarah Acaster; Binny Pinder; Clara Mukuria; Amanda Copans
Journal:  Health Qual Life Outcomes       Date:  2015-03-12       Impact factor: 3.186

3.  Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis.

Authors:  Justin E Ideozu; Xi Zhang; Amy Pan; Zainub Ashrafi; Katherine J Woods; Martin J Hessner; Pippa Simpson; Hara Levy
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

4.  Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  Phoebe E Griffin; Louise F Roddam; Yvonne C Belessis; Roxanne Strachan; Sean Beggs; Adam Jaffe; Margaret A Cooley
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

5.  Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study.

Authors:  Doug L Forrester; Alan J Knox; Alan R Smyth; Andrew W Fogarty
Journal:  J Cyst Fibros       Date:  2012-09-05       Impact factor: 5.482

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.